Carcinoma Squamous Cell clinical trials

Explore recruiting carcinoma squamous cell clinical trials.

Recruiting carcinoma squamous cell studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Carcinoma Squamous Cell trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study to investigate the safety and tolerability of intravenous QEQ278 in patients with advanced solid tumors

France, Italy, Germany, Belgium, Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Carcinoma Squamous Cell trials by city

Carcinoma Squamous Cell clinical trials

Recruiting carcinoma squamous cell studies right now

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma

A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizumab as First-line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus02)

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors

Also recruiting in Europe

A study to investigate the safety and tolerability of intravenous QEQ278 in patients with advanced solid tumors

Carcinoma Squamous Cell trials by city

Other conditions